{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T05:38:31Z","timestamp":1794375511810,"version":"4.9.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T00:00:00Z","timestamp":1760745600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.diabres.2025.112952","type":"journal-article","created":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:02:09Z","timestamp":1760911329000},"page":"112952","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Continuous Glucose Monitoring as an alternative for Cystic Fibrosis Related diabetes screening and diagnosis"],"prefix":"10.1016","volume":"229","author":[{"given":"I.","family":"Aguilera Garc\u00eda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"V\u00e1zquez P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"L\u00f3pez Plaza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Matabuena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.M.","family":"Garc\u00eda Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.Palma","family":"Milla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Zamarr\u00f3n de Lucas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.C.","family":"Prados S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Gonz\u00e1lez P\u00e9rez de Villar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.diabres.2025.112952_b0005","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.2337\/dc10-1279","article-title":"Epidemiology, pathophysiology, and prognostic implications of cystic fibrosis-related diabetes: a technical review","volume":"33","author":"Moran","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2025.112952_b0010","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1210\/clinem\/dgac020","article-title":"New Concepts in the Pathogenesis of Cystic Fibrosis-Related Diabetes","volume":"107","author":"Moheet","year":"2022","journal-title":"Journal of Clinical Endocrinology and Metabolism Endocrine Society"},{"key":"10.1016\/j.diabres.2025.112952_b0015","doi-asserted-by":"crossref","DOI":"10.1164\/ajrccm.162.3.9904075","article-title":"Trends in Pulmonary Function in patients with Cystic Fibrosis Correlate with the Degree of Glucose Intolerance at Baseline [internet]","volume":"Vol. 162","author":"Milla","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.diabres.2025.112952_b0020","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.jcf.2019.03.010","article-title":"Early glucose abnormalities are associated with pulmonary inflammation in young children with cystic fibrosis","volume":"18","author":"Prentice","year":"2019","journal-title":"J Cyst Fibros"},{"issue":"2","key":"10.1016\/j.diabres.2025.112952_b0025","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/ppul.24212","article-title":"Ventilation inhomogeneity is associated with OGTT-derived insulin secretory defects in cystic fibrosis","volume":"54","author":"Colombo","year":"2019","journal-title":"Pediatr Pulmonol"},{"issue":"6","key":"10.1016\/j.diabres.2025.112952_b0030","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.jcf.2018.03.008","article-title":"Continuous glucose monitoring abnormalities in cystic fibrosis youth correlate with pulmonary function decline","volume":"17","author":"Chan","year":"2018","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.diabres.2025.112952_b0035","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.jcf.2019.08.016","article-title":"Cystic fibrosis related diabetes: Pathophysiology, screening and diagnosis","volume":"18","author":"Granados","year":"2019","journal-title":"J Cyst Fibros"},{"issue":"2","key":"10.1016\/j.diabres.2025.112952_b0040","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jcf.2024.01.005","article-title":"Standards for the care of people with cystic fibrosis (CF); recognising and addressing CF health issues","volume":"23","author":"Burgel","year":"2024","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.diabres.2025.112952_b0045","unstructured":"Cystic Fibrosis Foundation. PATIENT REGISTRY ANNUAL DATA REPORT. 2023."},{"issue":"1","key":"10.1016\/j.diabres.2025.112952_b0050","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jcjd.2018.04.008","article-title":"Cystic Fibrosis-Related Diabetes Screening in adults: a Gap Analysis and Evaluation of Accuracy of Glycated Hemoglobin Levels","volume":"43","author":"Gilmour","year":"2019","journal-title":"Can J Diabetes"},{"key":"10.1016\/j.diabres.2025.112952_b0055","first-page":"208","article-title":"Novel time-saving OGTT sparing HbA1c-HOMA2 based algorithm for the diagnosis of cystic fibrosis-related diabetes","volume":"1","author":"Lurquin","year":"2024","journal-title":"Diabetes Res Clin Pract"},{"issue":"4","key":"10.1016\/j.diabres.2025.112952_b0060","doi-asserted-by":"crossref","first-page":"E1444","DOI":"10.1210\/clinem\/dgab857","article-title":"Continuous glucose monitoring and HbA1c in cystic fibrosis: clinical correlations and implications for CFRD diagnosis","volume":"107","author":"Scully","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.diabres.2025.112952_b0065","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.endinu.2017.08.008","article-title":"Oral glucose tolerance test and continuous glucose monitoring to assess diabetes development in cystic fibrosis patients","volume":"65","author":"Clemente Le\u00f3n","year":"2018","journal-title":"Endocrinol Diabetes Nutr"},{"issue":"2","key":"10.1016\/j.diabres.2025.112952_b0070","doi-asserted-by":"crossref","first-page":"E548","DOI":"10.1210\/clinem\/dgab692","article-title":"The Relationship between Continuous Glucose monitoring and OGTT in Youth and Young adults with Cystic Fibrosis","volume":"107","author":"Chan","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabres.2025.112952_b0075","first-page":"15","article-title":"Continuous glucose monitoring and advanced glycation endproducts for prediction of clinical outcomes and development of cystic fibrosis-related diabetes in adults with CF","volume":"6","author":"Scully","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.diabres.2025.112952_b0080","doi-asserted-by":"crossref","DOI":"10.1007\/s00592-025-02457-8","article-title":"Time to change guidelines? Suboptimal glycemic control measures by CGM associated with cystic fibrosis exacerbations despite adequate HbA1c","author":"Aguilera Garc\u00eda","year":"2025","journal-title":"Acta Diabetol"},{"issue":"5","key":"10.1016\/j.diabres.2025.112952_b0085","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jcf.2020.02.009","article-title":"Glucose abnormalities detected by continuous glucose monitoring are common in young children with Cystic Fibrosis","volume":"19","author":"Prentice","year":"2020","journal-title":"J Cyst Fibros"},{"issue":"5","key":"10.1016\/j.diabres.2025.112952_b0090","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.jcf.2021.01.002","article-title":"Abnormal glucose tolerance and lung function in children with cystic fibrosis. Comparing oral glucose tolerance test and continuous glucose monitoring","volume":"20","author":"Elidottir","year":"2021","journal-title":"J Cyst Fibros"},{"issue":"6","key":"10.1016\/j.diabres.2025.112952_b0095","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1177\/0962280221998064","article-title":"Glucodensities: a new representation of glucose profiles using distributional data analysis","volume":"30","author":"Matabuena","year":"2021","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/j.diabres.2025.112952_b0100","unstructured":"Oliv\u00e1n Bl\u00e1zquez B, Kang Johnson T, Angel Mu\u00f1oz M. Time above range for predicting the development of type 2 diabetes. 2022 Dec."},{"key":"10.1016\/j.diabres.2025.112952_b0105","unstructured":"Standards of Care in Diabetes 2025. Diabetes Care. 2025 Jan ;48."},{"issue":"5","key":"10.1016\/j.diabres.2025.112952_b0110","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.jcf.2024.06.009","article-title":"Feasibility and accuracy of at-home glucose tolerance tests for cystic fibrosis related diabetes screening","volume":"23","author":"Alexandre-Heymann","year":"2024","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.diabres.2025.112952_b0115","series-title":"Advances in diabetes technology to improve the lives of people with cystic fibrosis","author":"Scully","year":"2024"},{"issue":"10","key":"10.1016\/j.diabres.2025.112952_b0120","doi-asserted-by":"crossref","first-page":"4356","DOI":"10.1210\/jc.2018-02763","article-title":"Continuous glucose monitoring profiles in healthy nondiabetic participants: a multicenter prospective study","volume":"104","author":"Shah","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.diabres.2025.112952_b0125","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1177\/19322968241242487","article-title":"Continuous glucose monitoring for prediabetes: what are the best metrics?","volume":"18","author":"Zahalka","year":"2024","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/j.diabres.2025.112952_b0130","doi-asserted-by":"crossref","unstructured":"Matabuena M, Ghosal R, Aguilar JE, Wagner R, Merino CF, Castro JS, et al. Glucodensity Functional Profiles Outperform Traditional Continuous Glucose Monitoring Metrics. 2024 Oct 1.","DOI":"10.1038\/s41598-025-18119-2"},{"key":"10.1016\/j.diabres.2025.112952_b0135","unstructured":"Monitorin\u01f5oscar Lado-Baleato M, D\u00edaz-Louzao C, Gude F, Matabuena M. Optimal Cut-Point Estimation for Functional Digital Biomarkers: Application to Diabetes Risk Stratification via Continuous Glucose Monitoring. 2024 Apr 15."},{"key":"10.1016\/j.diabres.2025.112952_b0140","unstructured":"Matabuena M, Crainiceanu CM. Multilevel functional distributional models with application to continuous glucose monitoring in diabetes clinical trials. 2024 Mar 15."}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822725009660?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822725009660?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T14:27:28Z","timestamp":1764080848000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822725009660"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":28,"alternative-id":["S0168822725009660"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2025.112952","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Continuous Glucose Monitoring as an alternative for Cystic Fibrosis Related diabetes screening and diagnosis","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2025.112952","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"112952"}}